(February 26, 2019, 10:32 AM EST) -- NEWARK, N.J. — A New Jersey federal judge on Feb. 21 dismissed without prejudice a whistleblower case alleging that Novartis Pharmaceuticals Corp. and a pharmacy benefit manager conspired to discount a multiple sclerosis drug as a form of kickback to keep the drug on the manager’s drug formulary (United States of America, ex rel. Joseph Perri v. Novartis Pharmaceuticals Corp., et al., No. 15-6547, D. N.J., 2019 U.S. Dist. LEXIS 28594)....